Brian DeSchuytner
2021
Compensation breakdown
| Non-Equity Incentive Plan | $158,394 |
|---|---|
| Option Awards | $1,656,619 |
| Salary | $405,099 |
| Stock Awards | $527,250 |
| Other | $7,000 |
| Total | $2,754,362 |
DeSchuytner received $1.7M in option awards, accounting for 60% of the total pay in 2021.
DeSchuytner also received $158.4K in non-equity incentive plan, $405.1K in salary, $527.3K in stock awards and $7K in other compensation.
Rankings
In 2021, Brian DeSchuytner's compensation ranked 4,773rd out of 12,415 executives tracked by ExecPay. In other words, DeSchuytner earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,773 out of 12,415 | 62nd |
Division Manufacturing | 1,989 out of 5,501 | 64th |
Major group Chemicals And Allied Products | 838 out of 2,371 | 65th |
Industry group Drugs | 750 out of 2,092 | 64th |
Industry Pharmaceutical Preparations | 536 out of 1,542 | 65th |
Pay ratio
| Brian DeSchuytner's Pay | $2,754,362 |
|---|---|
| Median Employee's Pay | $302,642 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Brian DeSchuytner was $2,754,362.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Brian DeSchuytner's pay to the pay of median employee was therefore 9 to one.
DeSchuytner's colleagues
We found six more compensation records of executives who worked with Brian DeSchuytner at Mersana Therapeutics in 2021.
2021
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
2021
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2021
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
2021
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020